Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp shows a slight decrease today, losing -€0.020 (-0.480%) compared to yesterday.
Chromadex Corp is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
With a target price of 10 € there is potential for a 142.72% increase which would mean more than doubling the current price of 4.12 € for Chromadex Corp.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -0.480% | -4.186% | -21.524% | -22.264% | -25.091% | 146.633% | -35.118% |
| Intellia Therapeutics Inc | -1.940% | 7.421% | -1.558% | -7.969% | 37.586% | -71.512% | -82.034% |
| Cardio3 Biosciences S.A. | 42.950% | 73.541% | 225.547% | -12.720% | 230.370% | -62.584% | -93.020% |
| Polynovo Ltd | -5.360% | 0.000% | -15.200% | -52.679% | -22.059% | -62.937% | -66.242% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat